Centogene Current Valuation vs. Shares Owned By Insiders
CNTG Stock | USD 0.14 0.03 17.65% |
For Centogene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Centogene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Centogene B V utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Centogene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Centogene B V over time as well as its relative position and ranking within its peers.
Centogene |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Centogene B V Shares Owned By Insiders vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Centogene's current stock value. Our valuation model uses many indicators to compare Centogene value to that of its competitors to determine the firm's financial worth. Centogene B V is rated below average in current valuation category among its peers. It is rated below average in shares owned by insiders category among its peers . The ratio of Current Valuation to Shares Owned By Insiders for Centogene B V is about 15,168,817 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Centogene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Centogene Current Valuation vs. Competition
Centogene B V is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 11.47 Billion. Centogene maintains roughly 69.17 Million in current valuation contributing less than 1% to equities under Health Care industry.
Centogene Shares Owned By Insiders vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Centogene |
| = | 69.17 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Centogene |
| = | 4.56 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Centogene Shares Owned By Insiders Comparison
Centogene is currently under evaluation in shares owned by insiders category among its peers.
Centogene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Centogene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Centogene will eventually generate negative long term returns. The profitability progress is the general direction of Centogene's change in net profit over the period of time. It can combine multiple indicators of Centogene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany. Centogene operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 808 people.
Centogene Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Centogene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Centogene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Centogene's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Centogene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Use Investing Themes to Complement your Centogene position
In addition to having Centogene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Index Thematic Idea Now
Macroaxis Index
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
View All Next | Launch |
Check out Trending Equities. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
To fully project Centogene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Centogene B V at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Centogene's income statement, its balance sheet, and the statement of cash flows.